« Back
Home /
Tifcemalimab

Tifcemalimab

€295.00

Excl. VAT

Item no.	HY-P99961-1mg
Manufacturer	MedChem Express
Amount	1 mg
Category	Antibodies In Vivo Antibodies
Type	Antibody Monoclonal
Specific against	other
Purity	95.00
Dry ice	Yes
Citations	[1]Jun M, et, al. Phase I Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas. Blood (2022) 140 (Supplement 1): 3716–3717.
Smiles	[Tifcemalimab]
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	JS004
Available
Product Description	Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer[1].
StorageTemperature	Store at -80°C for 2 years
Shipping	Dry Ice
Manufacturers Applications	Cancer-programmed cell death
Molecular Weight	N/A
Clinical Information	Phase 2
Solubility	10 mM in DMSO
Pathway	Immunology/Inflammation
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

Listprice: €295.00

Price: €295.00

available

Quantity:

Compare

Add to wishlist